Nature of AE or practice* | Type of economic evaluation | Data source or technique for AE identification* | |||||||||
Cost studies | Complete evaluations* | Surveillance systems | Professional assessment | Laboratory | Administrative records | Literature | Not stated/not concerned | ||||
Cost of AEs | Cost of safety practices | CEA | CUA | CBA | |||||||
Several types of AE/comprehensive PSP | 24 | 25 26 | None | None | 27 28 | None | 24 | None | None | 27 | 25 |
HAIs and/or infection control activities | 29–44 | 25 45 | 46 47 | 48 | 46–48 | 33 34 38 39 41 42 46 47 49 | 29 31 35 43 | 29 37 43 44 | 30 32 36 | 48 | 25 26 28 40 45 |
Medication related | 50 | None | 51–54 | 55 | 55 | None | 51 53 | 52 | 50 | 54 55 | None |
Perioperative care | None | None | None | 56 | None | None | None | None | 56 | None | None |
↵* Categories are not mutually exclusive.
AE, adverse event; CEA, cost-effectiveness analysis; CBA, cost-benefit analysis; CUA, cost-utility analysis; HAI, healthcare-associated infection; PSP, patient safety practices.